Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis

International Urology and Nephrology

Volumn 44, Issue 1, 2012, Pages 183-196

  Taneda, Sekiko ^a   Honda, Kazuho ^a   Uchida, Keiko ^a   Nitta, Kosaku ^a   Yumura, Wako ^b   Oda, Hideaki ^a   Nagata, Michio ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cellular; Collapsing; Columbia classification; Fibrous; Focal segmental glomerulosclerosis; Not otherwise specified; Perihilar; Segmental lesion; Tip

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; APHERESIS; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HISTOLOGICAL HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION TEST; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PROTEIN URINE LEVEL; PROTEINURIA; ADOLESCENT; ANALYSIS OF VARIANCE; BIOPSY; BLOOD; CHRONIC KIDNEY FAILURE; CLASSIFICATION; DISEASE COURSE; GLOMERULUS; HOSPITALIZATION; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; CREATININE; DISEASE PROGRESSION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MIDDLE AGED; PROTEINURIA; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STEROIDS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861112050     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9932-y     Document Type: Article

References (23)

1. Schwartz MM, Evans J, Bain R et al (1999) Focal seg-mental glomerulosclerosis: prognostic implications of the cellular lesion. J Am Soc Nephrol 10:1900-1907
2. D'Agati VD (2008) The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens 17:271-281
3. D'Agati VD, Fogo AB, Bruijn JA et al (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368-382
4. Stokes MB, Markowitz GS, Lin J et al (2004) Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690-1702
5. Thomas DB, Franceschini N, Hogan SL et al (2006) Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926
6. Stokes MB, Valeri AM, Markowitz GS et al (2006) Cel-lular focal segmental glomerulosclerosis: clinical and pathologic features. Kidney Int 70:1783-1792
7. Howie AJ, Pankhurst T, Sarioglu S et al (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int 67:987-1001
8. Silverstein DM, Craver R (2007) Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2:700-707
9. IJ DH, Farris AB, Goemaere N et al (2008) Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 19:2219-2224
10. Canaud G, Dion D, Zuber J et al (2009) Recurrence of nephrotic syndrome after transplantation in a mixed pop-ulation of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants offocal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 25:1321-1328
11. Schwartz MM, Korbet SM (1993) Primary focal segmental glomerulosclerosis: pathology, histological variants, and pathogenesis. Am J Kidney Dis 22:874-883
12. Weening JJ, D'Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus ery-thematosus revisited. J Am Soc Nephrol 15:241-250
13. Shigematsu H (1997) Histological grading and staging of IgA nephropathy. Pathol Int 47:194-202
14. Taneda S, Honda K, Nitta K et al (1999) Clinicopatho-logical study of IgA nephropathy in adults: the influence of onset age on clinical and renal histological findings and on the effect of steroid therapy. Clin Exp Nephrol 3:96-103
15. Honda K, Nitta K, Kobayashi H et al (2000) Clinical sig-nificance of histological grading and staging for predicting the effectiveness of steroid therapy in IgA nephropathy. Clin Exp Nephrol 4:241-250
16. Suzuki S, Joh K (2004) Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria. Clin Exp Nephrol 8:109-116
17. Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinico-pathological correlations, and classification. Kidney Int 76: 534-545
18. Valeri A, Barisoni L, Appel GB et al (1996) Idiopathic collapsing focal segmental glomerulosclerosis: a clinico-pathologic study. Kidney Int 50:1734-1746
19. Detwiler RK, Falk RJ, Hogan SL et al (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424
20. Schwartz MM, Lewis EJ (1985) Focal segmental glomer-ular sclerosis: the cellular lesion. Kidney Int 28:968-974
21. Weiss MA, Daquioag E, Margolin EG et al (1986) Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am J Kidney Dis 7:20-28
22. Chun MJ, Korbet SM, Schwartz MM et al (2004) Focal segmental glomerulosclerosis in nephrotic adults: presen-tation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169-2177
23. Nair R (2006) Focal segmental glomerulosclerosis: cellular variant and beyond. Kidney Int 70:1676-1678